BioSpace News Archive

ABIOMED, Inc. today announced financial results for the quarter ended December 31, 2021.

Salarius Pharmaceuticals, Inc. today announced that Daniela Santiesteban, Ph.D., has been named Director of the Company’s new targeted protein degradation program.

New Intellectual Property Strengthens Company’s Scientific Thought Leadership in Targeting Hippo Pathway to Combat Cancer.

AnPac Bio-Medical Science Co., Ltd. announced today that it has filed for a Breakthrough device designation request for its cancer differentiation analysis (CDA) technology based medical device with the Food and Drug Administration (FDA) on February 1, 2022.

Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD) today announced it will host its fourth quarter and full year 2021 investor update conference call and webcast at 8:30 a.m. Eastern Time on Thursday, February 17, 2022.

Surmodics, Inc. today announced results for its fiscal 2022 first quarter ended December 31, 2021.

Akoya Biosciences, Inc., The Spatial Biology Company®, announced that it will be virtually participating in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference.

Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, announced that the Company has expanded its Clinical Operations Team with the hiring of a Director of Clinical Operations.

Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) announced the publication of new findings from its long-term safety study showing reductions in migraine frequency.

Kintor Pharmaceutical Limited today announced the dosing of first subject in its U.S. phase I clinical trial of GT20029.